TY - JOUR AU - Calo-Fernandez, B. AU - Martinez-Hurtado, J. L. PY - 2012 DA - 2012// TI - Biosimilars: company strategies to capture value from the biologics market JO - Pharmaceuticals VL - 5 UR - https://doi.org/10.3390/ph5121393 DO - 10.3390/ph5121393 ID - Calo-Fernandez2012 ER - TY - JOUR AU - Choy, E. AU - Jacobs, I. A. PY - 2014 DA - 2014// TI - Biosimilar safety considerations in clinical practice JO - Semin Oncol VL - 41 UR - https://doi.org/10.1053/j.seminoncol.2013.12.001 DO - 10.1053/j.seminoncol.2013.12.001 ID - Choy2014 ER - TY - STD TI - Church RF, Druckman MN, Wright E (2009) Biosimilars: What differences between the EU and the US? Scrip World Pharmaceuticals News Supplement ID - ref3 ER - TY - STD TI - Deloitte (2015) Winning with biosimilars Opportunities in global markets. http://www2.deloitte.com/content/dam/Deloitte/us/Documents/life-sciences-health-care/us-lshc-biosimilars-whitepaper-final.pdf. Accessed 17 May 2016 UR - http://www2.deloitte.com/content/dam/Deloitte/us/Documents/life-sciences-health-care/us-lshc-biosimilars-whitepaper-final.pdf ID - ref4 ER - TY - STD TI - European Medicines Agency (2016) European public assessment reports. http://www.ema.europa.eu/ema/index.jsp?curl=pages%2Fmedicines%2Flanding%2Fepar_search.sp&mid=WC0b01ac058001d124&searchTab=searchByAuthType&alreadyLoaded=true&isNewQuery=true&status=Authorised&keyword=Enter+keywords&searchType=name&taxonomyPath=&treeNumber=&searchGenericType=biosimilars&genericsKeywordSearch=Submit. Accessed 05 Oct 2016 UR - http://www.ema.europa.eu/ema/index.jsp?curl=pages%2Fmedicines%2Flanding%2Fepar_search.sp&mid=WC0b01ac058001d124&searchTab=searchByAuthType&alreadyLoaded=true&isNewQuery=true&status=Authorised&keyword=Enter+keywords&searchType=name&taxonomyPath=&treeNumber=&searchGenericType=biosimilars&genericsKeywordSearch=Submit ID - ref5 ER - TY - STD TI - FDA (2009) Biologics price competition and innovation act of 2009. Technical report, Food and Drug Administration, Silver Spring, MD, USA ID - ref6 ER - TY - STD TI - FDA (2010) Approval pathway for biosimilar and interchangeable biological products public meeting. http://www.fda.gov/Drugs/NewsEvents/ucm221688.htm. Accessed 17 May 2016 UR - http://www.fda.gov/Drugs/NewsEvents/ucm221688.htm ID - ref7 ER - TY - JOUR AU - Felix, A. E. AU - Gupta, A. AU - Cohen, J. P. AU - Riggs, K. PY - 2014 DA - 2014// TI - Barriers to market uptake of biosimilars in the US JO - GaBI J VL - 3 UR - https://doi.org/10.5639/gabij.2014.0303.028 DO - 10.5639/gabij.2014.0303.028 ID - Felix2014 ER - TY - STD TI - IMS Health (2011) Shaping the biosimilars opportunity: a global perspective on the evolving biosimilars landscape. http://www.imshealth.com/ims/Global/Content/Home%20Page%20Content/IMS%20News/Biosimilars_Whitepaper.pdf. Accessed 17 May 2016 UR - http://www.imshealth.com/ims/Global/Content/Home%20Page%20Content/IMS%20News/Biosimilars_Whitepaper.pdf ID - ref9 ER - TY - STD TI - Jordan Food and Drug Administration (2016) laws and regulations. http://www.jfda.jo/. Accessed 17 May 2016 UR - http://www.jfda.jo/ ID - ref10 ER - TY - JOUR AU - Kresse, G. B. PY - 2009 DA - 2009// TI - Biosimilars-Science, status and strategic perspective JO - Eur J Pharm Biopharm VL - 72 UR - https://doi.org/10.1016/j.ejpb.2009.02.014 DO - 10.1016/j.ejpb.2009.02.014 ID - Kresse2009 ER - TY - JOUR AU - Liang, B. AU - Mackey, T. PY - 2012 DA - 2012// TI - Tipping point: Biosimilars, emerging markets, and public-private engagement to promote global health JO - J Commer Biotechnol VL - 18 UR - https://doi.org/10.5912/jcb562 DO - 10.5912/jcb562 ID - Liang2012 ER - TY - STD TI - Lockwood C, Reinaud F, Marinoni G, Ando G (2013) Biosimilar and originator biologic pricing, dynamics in emerging markets. HIS Healthcare and Pharma. http://www.ihs.com/pdfs/Biologics-Emerging-Markets-oct-2013.pdf. Accessed 17 May 2016 UR - http://www.ihs.com/pdfs/Biologics-Emerging-Markets-oct-2013.pdf ID - ref13 ER - TY - JOUR AU - Nick, C. PY - 2012 DA - 2012// TI - The US biosimilars act: challenges facing regulatory approval JO - Pharm Med VL - 26 UR - https://doi.org/10.1007/BF03262388 DO - 10.1007/BF03262388 ID - Nick2012 ER - TY - STD TI - Republic of Lebanon (2013) Ministry of Public Health. Quality Assurance of Pharmaceutical Products Program Implementation. Dr. Rita Karam ESA 2013. http://www.moph.gov.lb/Media/Documents/QAPP.pdf. Accessed 17 May 2016 UR - http://www.moph.gov.lb/Media/Documents/QAPP.pdf ID - ref15 ER - TY - JOUR AU - Simoens, S. AU - Verbeken, G. AU - Huys, I. PY - 2011 DA - 2011// TI - Market access of biosimilars: not only a cost issue JO - Oncologie VL - 13 UR - https://doi.org/10.1007/s10269-011-2018-8 DO - 10.1007/s10269-011-2018-8 ID - Simoens2011 ER - TY - JOUR AU - Sylvester, K. AU - Rocchio, M. AU - Beik, N. AU - Fanikos, J. PY - 2013 DA - 2013// TI - Biosimilars: an emerging category of biologic drugs for emergency medicine practitioners JO - Curr Emerg Hosp Med Rep VL - 1 UR - https://doi.org/10.1007/s40138-013-0023-5 DO - 10.1007/s40138-013-0023-5 ID - Sylvester2013 ER - TY - STD TI - US Code (2012) Legal Information Institute, 42 U.S. Code § 262—Regulation of biological products. http://www.law.cornell.edu/uscode/text/42/262. Accessed 17 May 2016 UR - http://www.law.cornell.edu/uscode/text/42/262 ID - ref18 ER - TY - STD TI - U.S. Department of Health and Human Services, Food and Drug Administration (2016a) News % Events. FDA approves first biosimilar product Zarxio. http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm436648.htm. Accessed 05 Oct 2016 UR - http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm436648.htm ID - ref19 ER - TY - STD TI - U.S. Department of Health and Human Services, Food and Drug Administration (2016b) News % Events. FDA approves Inflectra, a biosimilar to Remicade. http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm494227.htm. Accessed 05 Oct 2016 UR - http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm494227.htm ID - ref20 ER - TY - STD TI - U.S. Department of Health and Human Services, Food and Drug Administration (2016c) News % Events. FDA approves Erelzi, a biosimilar to Enbrel. http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm518639.htm. Accessed 05 Oct 2016 UR - http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm518639.htm ID - ref21 ER - TY - STD TI - U.S. Department of Health and Human Services, Food and Drug Administration (2016d) News % Events. FDA approves Amjevita, a biosimilar to Humira. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm522243.htm. Accessed 05 Oct 2016 UR - http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm522243.htm ID - ref22 ER - TY - STD TI - U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER) (2015a) Scientific Considerations in Demonstrating Biosimilarity to a Reference Product Guidance for Industry April 2015. Biosimilarity. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM291128.pdf. Accessed 17 May 2016 UR - http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM291128.pdf ID - ref23 ER - TY - STD TI - U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER) (2015b) Quality Considerations in Demonstrating Biosimilarity of a Therapeutic Protein Product to a Reference Product Guidance for Industry. Biosimilarity. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM291134.pdf. Accessed 17 May 2016 UR - http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM291134.pdf ID - ref24 ER - TY - STD TI - U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER) (2016) Biosimilars: Additional Questions and Answers Regarding Implementation of the Biologics Price Competition and Innovation Act of 2009 Guidance for Industry Draft Guidance. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM273001.pdf. Accessed 17 May 2016 UR - http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM273001.pdf ID - ref25 ER - TY - STD TI - World Health Organization (2006) Regional health systems observatory-EMRO. Health system profile: Lebanon. http://hinfo.humaninfo.ro/gsdl/healthtechdocs/documents/s17301e/s17301e.pdf. Accessed 17 May 2016 UR - http://hinfo.humaninfo.ro/gsdl/healthtechdocs/documents/s17301e/s17301e.pdf ID - ref26 ER -